India is all set to launch on Thursday its first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for prevention of cervical cancer. It has been developed by the Serum Institute of India in partnership with the Department of Biotechnology. Till now, HPV vaccines needed to prevent cervical cancer have been sourced from foreign manufacturers at a cost of Rs 2,000 to Rs 3,500 per dose.
from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/Xj2fCTb
via ATC
Wednesday 31 August 2022
August 31, 2022
MR: EDITOR
ATC ALL TIPS N CLIPS
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment